Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
LINEAGE INC has an operating margin of -6.8%, meaning the company retains $-7 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 7.4% the prior year.
LINEAGE INC's revenue grew a modest -0.0% year-over-year to $5.3B. This slow but positive growth earns a score of 28/100.
LINEAGE INC carries a low D/E ratio of 0.57, meaning only $0.57 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.
LINEAGE INC's current ratio of 0.86 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 14/100, which could limit financial flexibility.
While LINEAGE INC generated $703.0M in operating cash flow, capex of $691.0M consumed most of it, leaving $12.0M in free cash flow. This results in a low score of 1/100, reflecting heavy capital investment rather than weak cash generation.
LINEAGE INC passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, LINEAGE INC generates $-1.06 in operating cash flow ($703.0M OCF vs -$664.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
LINEAGE INC earns $-0.8 in operating income for every $1 of interest expense (-$361.0M vs $426.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
This page shows LINEAGE INC (LINE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
LINEAGE INC generated $5.3B in revenue in fiscal year 2024. This represents a decrease of 0.0% from the prior year.
LINEAGE INC's EBITDA was $515.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 55.5% from the prior year.
LINEAGE INC generated $12.0M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 60.0% from the prior year.
LINEAGE INC reported -$664.0M in net income in fiscal year 2024. This represents a decrease of 762.3% from the prior year.
LINEAGE INC earned $-3.70 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 406.8% from the prior year.
LINEAGE INC held $173.0M in cash against $4.9B in long-term debt as of fiscal year 2024.
LINEAGE INC paid $0.91 per share in dividends in fiscal year 2024. This represents an increase of 65.5% from the prior year.
LINEAGE INC had 228M shares outstanding in fiscal year 2024. This represents an increase of 40.8% from the prior year.
LINEAGE INC's gross margin was 33.0% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.
LINEAGE INC's operating margin was -6.8% in fiscal year 2024, reflecting core business profitability. This is down 14.2 percentage points from the prior year.
LINEAGE INC's net profit margin was -12.4% in fiscal year 2024, showing the share of revenue converted to profit. This is down 11.0 percentage points from the prior year.
LINEAGE INC spent $25.0M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 108.3% from the prior year.
LINEAGE INC invested $691.0M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 9.8% from the prior year.
LINE Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4B+2.0% | $1.4B+4.5% | $1.3B-3.5% | $1.3B+0.1% | $1.3B+0.8% | $1.3B | N/A | $1.3B |
| Cost of Revenue | $932.0M+1.3% | $920.0M+5.0% | $876.0M-3.3% | $906.0M+1.7% | $891.0M+0.8% | $884.0M | N/A | $899.0M |
| Gross Profit | $445.0M+3.5% | $430.0M+3.4% | $416.0M-3.9% | $433.0M-3.1% | $447.0M+0.7% | $444.0M | N/A | $430.0M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $145.0M+1.4% | $143.0M-7.1% | $154.0M+6.2% | $145.0M+14.2% | $127.0M+2.4% | $124.0M | N/A | $122.0M |
| Operating Income | $35.0M+52.2% | $23.0M-58.9% | $56.0M+366.7% | -$21.0M-128.4% | $74.0M-26.7% | $101.0M | N/A | $97.0M |
| Interest Expense | $67.0M+4.7% | $64.0M+12.3% | $57.0M-3.4% | $59.0M-58.5% | $142.0M+2.9% | $138.0M | N/A | $131.0M |
| Income Tax | $11.0M+257.1% | -$7.0M-187.5% | $8.0M+119.5% | -$41.0M-685.7% | $7.0M+170.0% | -$10.0M | N/A | -$5.0M |
| Net Income | -$100.0M-1566.7% | -$6.0M | $0+100.0% | -$71.0M-4.4% | -$68.0M-70.0% | -$40.0M | N/A | -$39.0M |
| EPS (Diluted) | $-0.44-1366.7% | $-0.03-400.0% | $0.01+101.9% | $-0.52-13.0% | $-0.46-64.3% | $-0.28 | N/A | $-0.26 |
LINE Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $19.2B-1.3% | $19.4B+3.6% | $18.8B+0.6% | $18.7B-0.5% | $18.8B | N/A | $18.9B | N/A |
| Current Assets | $1.3B-4.9% | $1.3B-3.0% | $1.4B+8.2% | $1.3B-4.0% | $1.3B | N/A | $1.3B | N/A |
| Cash & Equivalents | $75.0M-8.5% | $82.0M-58.4% | $197.0M+13.9% | $173.0M+137.0% | $73.0M-22.3% | $94.0M+38.2% | $68.0M-39.3% | $112.0M |
| Inventory | $167.0M-4.0% | $174.0M-0.6% | $175.0M-6.4% | $187.0M+8.7% | $172.0M | N/A | $171.0M | N/A |
| Accounts Receivable | $857.0M-3.8% | $891.0M+5.2% | $847.0M+2.5% | $826.0M-13.4% | $954.0M | N/A | $913.0M | N/A |
| Goodwill | $3.5B-0.9% | $3.5B+3.7% | $3.4B+1.2% | $3.3B-0.7% | $3.4B | N/A | $3.4B | N/A |
| Total Liabilities | $9.8B+0.3% | $9.8B+7.2% | $9.1B+1.7% | $9.0B-31.0% | $13.0B | N/A | $12.8B | N/A |
| Current Liabilities | $1.3B-8.4% | $1.4B+0.4% | $1.4B-5.9% | $1.5B+22.2% | $1.2B | N/A | $1.4B | N/A |
| Long-Term Debt | $5.9B+3.3% | $5.7B+11.8% | $5.1B+4.6% | $4.9B-47.3% | $9.3B | N/A | $9.0B | N/A |
| Total Equity | $8.4B-2.9% | $8.6B+0.6% | $8.6B-0.6% | $8.6B+77.1% | $4.9B-13.0% | $5.6B+11.0% | $5.1B-12.9% | $5.8B |
| Retained Earnings | -$2.3B-10.6% | -$2.1B-6.4% | -$2.0B-6.5% | -$1.9B-87.9% | -$987.0M | N/A | -$879.0M | N/A |
LINE Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $230.0M-10.9% | $258.0M+85.6% | $139.0M-45.9% | $257.0M+65.8% | $155.0M+47.6% | $105.0M-54.5% | $231.0M+0.9% | $229.0M |
| Capital Expenditures | $195.0M+19.6% | $163.0M+7.9% | $151.0M-26.3% | $205.0M+10.2% | $186.0M+26.5% | $147.0M-8.7% | $161.0M-9.0% | $177.0M |
| Free Cash Flow | $35.0M-63.2% | $95.0M+891.7% | -$12.0M-123.1% | $52.0M+267.7% | -$31.0M+26.2% | -$42.0M-160.0% | $70.0M+34.6% | $52.0M |
| Investing Cash Flow | -$181.0M+68.8% | -$580.0M-320.3% | -$138.0M+64.0% | -$383.0M-95.4% | -$196.0M+3.0% | -$202.0M+52.0% | -$421.0M-120.4% | -$191.0M |
| Financing Cash Flow | -$54.0M-126.3% | $205.0M+876.2% | $21.0M+119.4% | -$108.0M-569.6% | $23.0M-81.0% | $121.0M-17.1% | $146.0M+328.1% | -$64.0M |
| Dividends Paid | $134.0M0.0% | $134.0M0.0% | $134.0M+39.6% | $96.0M+772.7% | $11.0M-90.2% | $112.0M+143.5% | $46.0M | $0 |
| Share Buybacks | $0 | $0 | $0 | $0 | $0-100.0% | $25.0M+177.8% | $9.0M | $0 |
LINE Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.3%+0.5pp | 31.9%-0.4pp | 32.2%-0.1pp | 32.3%-1.1pp | 33.4%-0.0pp | 33.4% | N/A | 32.4% |
| Operating Margin | 2.5%+0.8pp | 1.7%-2.6pp | 4.3%+5.9pp | -1.6%-7.1pp | 5.5%-2.1pp | 7.6% | N/A | 7.3% |
| Net Margin | -7.3%-6.8pp | -0.4%-0.4pp | 0.0%+5.3pp | -5.3%-0.2pp | -5.1%-2.1pp | -3.0% | N/A | -2.9% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -0.5%-0.5pp | -0.0%-0.0pp | 0.0%+0.4pp | -0.4%-0.0pp | -0.4% | N/A | N/A | N/A |
| Current Ratio | 0.99+0.0 | 0.96-0.0 | 0.99+0.1 | 0.86-0.2 | 1.10 | N/A | 0.92 | N/A |
| Debt-to-Equity | 0.71+0.0 | 0.66+0.1 | 0.60+0.0 | 0.57-1.3 | 1.91 | N/A | 1.77 | N/A |
| FCF Margin | 2.5%-4.5pp | 7.0%+8.0pp | -0.9%-4.8pp | 3.9%+6.2pp | -2.3%+0.8pp | -3.2% | N/A | 3.9% |
Note: The current ratio is below 1.0 (0.86), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is LINEAGE INC's annual revenue?
LINEAGE INC (LINE) reported $5.3B in total revenue for fiscal year 2024. This represents a -0.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is LINEAGE INC's revenue growing?
LINEAGE INC (LINE) revenue grew by 0% year-over-year, from $5.3B to $5.3B in fiscal year 2024.
Is LINEAGE INC profitable?
No, LINEAGE INC (LINE) reported a net income of -$664.0M in fiscal year 2024, with a net profit margin of -12.4%.
What is LINEAGE INC's earnings per share (EPS)?
LINEAGE INC (LINE) reported diluted earnings per share of $-3.70 for fiscal year 2024. This represents a -406.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is LINEAGE INC's EBITDA?
LINEAGE INC (LINE) had EBITDA of $515.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does LINEAGE INC have?
As of fiscal year 2024, LINEAGE INC (LINE) had $173.0M in cash and equivalents against $4.9B in long-term debt.
What is LINEAGE INC's gross margin?
LINEAGE INC (LINE) had a gross margin of 33.0% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is LINEAGE INC's operating margin?
LINEAGE INC (LINE) had an operating margin of -6.8% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is LINEAGE INC's net profit margin?
LINEAGE INC (LINE) had a net profit margin of -12.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does LINEAGE INC pay dividends?
Yes, LINEAGE INC (LINE) paid $0.91 per share in dividends during fiscal year 2024.
What is LINEAGE INC's free cash flow?
LINEAGE INC (LINE) generated $12.0M in free cash flow during fiscal year 2024. This represents a -60.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is LINEAGE INC's operating cash flow?
LINEAGE INC (LINE) generated $703.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are LINEAGE INC's total assets?
LINEAGE INC (LINE) had $18.7B in total assets as of fiscal year 2024, including both current and long-term assets.
What are LINEAGE INC's capital expenditures?
LINEAGE INC (LINE) invested $691.0M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
Does LINEAGE INC buy back shares?
Yes, LINEAGE INC (LINE) spent $25.0M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
How many shares does LINEAGE INC have outstanding?
LINEAGE INC (LINE) had 228M shares outstanding as of fiscal year 2024.
What is LINEAGE INC's current ratio?
LINEAGE INC (LINE) had a current ratio of 0.86 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is LINEAGE INC's debt-to-equity ratio?
LINEAGE INC (LINE) had a debt-to-equity ratio of 0.57 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is LINEAGE INC's return on assets (ROA)?
LINEAGE INC (LINE) had a return on assets of -3.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is LINEAGE INC's Piotroski F-Score?
LINEAGE INC (LINE) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are LINEAGE INC's earnings high quality?
LINEAGE INC (LINE) has an earnings quality ratio of -1.06x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can LINEAGE INC cover its interest payments?
LINEAGE INC (LINE) has an interest coverage ratio of -0.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is LINEAGE INC?
LINEAGE INC (LINE) scores 27 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.